![Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2004/nejm_2004.350.issue-22/nejmoa031918/production/images/img_medium/nejmoa031918_t2.jpeg)
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter | NEJM
![Table 2 from Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. | Semantic Scholar Table 2 from Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/12aed22c0affb1decf9e7953f12f3a9fb0849553/22-Table2-1.png)
Table 2 from Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. | Semantic Scholar
![Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine](https://www.thelancet.com/cms/attachment/624cfadd-1edd-4a95-853e-6264e72dfd82/gr1_lrg.jpg)
Improving the diagnosis of prostate cancer by telomerase-positive circulating tumor cells: A prospective pilot study - eClinicalMedicine
![Ontario Ministry of Health and Long-Term Care - Health Care Providers Section - Publications - Cancer - Ontario Prostate Specific Antigen (PSA) Clinical Guidelines Ontario Ministry of Health and Long-Term Care - Health Care Providers Section - Publications - Cancer - Ontario Prostate Specific Antigen (PSA) Clinical Guidelines](https://www.health.gov.on.ca/english/providers/pub/cancer/psa/psa_guide/psa.gif)
Ontario Ministry of Health and Long-Term Care - Health Care Providers Section - Publications - Cancer - Ontario Prostate Specific Antigen (PSA) Clinical Guidelines
![Prostate-Specific Antigen Within the Reference Range, Subclinical Coronary Atherosclerosis, and Cardiovascular Mortality | Circulation Research Prostate-Specific Antigen Within the Reference Range, Subclinical Coronary Atherosclerosis, and Cardiovascular Mortality | Circulation Research](https://www.ahajournals.org/cms/asset/cb19e14f-b3bb-4a13-abba-cc81bdf9ac9c/1492fig01.gif)
Prostate-Specific Antigen Within the Reference Range, Subclinical Coronary Atherosclerosis, and Cardiovascular Mortality | Circulation Research
![Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate](https://indianjurol.com/articles/2014/30/1/images/IndianJUrol_2014_30_1_28_124202_t3.jpg)
Free to total serum prostate specific antigen ratio in symptomatic men does not help in differentiating benign from malignant disease of the prostate
![Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions | Scientific Reports Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-04116-8/MediaObjects/41598_2021_4116_Fig1_HTML.png)
Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions | Scientific Reports
![Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2016/jco.2015.65.34.issue-23/jco.2016.66.7527/20161107/images/medium/jco667527t3.gif)
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology
![Prostate-Specific Antigen Testing: Overview, Physiologic Characteristics of PSA, Other Prostate Cancer Markers Prostate-Specific Antigen Testing: Overview, Physiologic Characteristics of PSA, Other Prostate Cancer Markers](https://img.medscapestatic.com/pi/meds/ckb/07/23507tn.jpg)
Prostate-Specific Antigen Testing: Overview, Physiologic Characteristics of PSA, Other Prostate Cancer Markers
![Correlation between prostate specific antigen levels and various prostatic pathologies Banerjee B, Iqbal BM, Kumar H, Kambale T, Bavikar R - J Med Soc Correlation between prostate specific antigen levels and various prostatic pathologies Banerjee B, Iqbal BM, Kumar H, Kambale T, Bavikar R - J Med Soc](https://www.jmedsoc.org/articles/2016/30/3/images/JMedSoc_2016_30_3_172_191184_b1.jpg)
Correlation between prostate specific antigen levels and various prostatic pathologies Banerjee B, Iqbal BM, Kumar H, Kambale T, Bavikar R - J Med Soc
![of cancer stage in patients with prostate cancer according to serum PSA... | Download Scientific Diagram of cancer stage in patients with prostate cancer according to serum PSA... | Download Scientific Diagram](https://www.researchgate.net/publication/313738598/figure/tbl2/AS:614288326672428@1523469158987/of-cancer-stage-in-patients-with-prostate-cancer-according-to-serum-PSA-levels.png)